Browse 65 Market Data Tables and 27 Figures spread through 155 Pages and in-depth TOC on "Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/endoscope-reprocessing-market-219094994.html
Early buyers will receive 10% customization on reports.
Automated Endoscope Reprocessors (AERs) to account for the largest share of the endoscope reprocessing market in 2017
On the basis of products, the market is segmented into high-level disinfectants and test strips; detergents and wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). The high-level disinfectants and test strips segment is expected to account for the largest share of the global endoscope reprocessing market in 2017. The large share of this segment is attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.
Hospitals segment expected to account for the largest share of the market in 2017
On the basis of end user, the endoscope reprocessing market has been segmented into hospitals, ambulatory surgery centers, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2017, the hospitals segment is expected to account for the largest share of the global endoscope reprocessing market. The ambulatory surgery centers (ASCs) segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. The high growth in this segment can be attributed to the increase in the number of endoscopic procedures performed in ASCs, and rising preference of ASCs over hospitals.
North America dominated the market in 2017
North America accounted for the largest share of the endoscope reprocessing market in 2017, followed by Europe. In the US, the endoscope reprocessing market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections. In Canada, the growth of the endoscope reprocessing market is driven by the availability of physician bonuses, and implementation of a new funding model for Canadian hospitals.